MedPath

Effect of Theta Burst Stimulation on depressive symptoms and craving in Alcohol Dependence with co-morbid Depressio

Phase 2
Conditions
Health Condition 1: F102- Alcohol dependenceHealth Condition 2: F341- Dysthymic disorderHealth Condition 3: F33- Major depressive disorder, recurrentHealth Condition 4: F32- Major depressive disorder, singleepisode
Registration Number
CTRI/2023/12/060572
Lead Sponsor
Central Institute of Psychiatry
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients diagnosed with Mental and Behavioral disorders due to use of alcohol, dependence syndrome, currently using the substance-active dependence (F10.24), along with, Depressive episode (F32) or Recurrent depressive disorder (F33) or Dysthymia (F34.1) according to ICD-10.

2.Clinical Institute Withdrawal Assessment for Alcohol revised (CIWA-Ar) score <10

3.Ready to give informed consent

4.Right-handed

Exclusion Criteria

1.Any other co-morbid substance abuse except Nicotine and Caffeine.

2.Any co-morbid psychiatric disorders except the ones mentioned in Inclusion criteria 1.

3.Patients having metallic implant.

4.Patients having known contra-indications to undergoing Theta Burst Stimulation or fMRI.

5.History of Electro-convulsive therapy or other Neuromodulation techniques within last 3 weeks.

6.Patient on any anti-craving medication during study period and preceding 4 weeks.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Change in the score of Alcohol Craving Questionnaire (ACQ-NOW) from baseline to end of last cTBS session and after 14 days from last cTBS session. <br/ ><br>2.Change in the score of obsessive-compulsive drinking scale (OCDS) from baseline to the end of last cTBS session and 14 days from last cTBS session. <br/ ><br>3.Change in HAM-D scores from baseline to end of last cTBS session and 14 days from last cTBS session. <br/ ><br>4.Change in MADRS scores from baseline to end of last cTBS session and 14 days from last cTBS session. <br/ ><br>5.Change in HAM-A scores from baseline to end of last cTBS session and 14 days from last cTBS session.Timepoint: Baseline, Day 8, Day 21
Secondary Outcome Measures
NameTimeMethod
1.Change in resting state functional connectivity of the Ventral Salience network and Default mode network from baseline to end of last cTBS session. <br/ ><br>2.Change in cue-related functional connectivity of the Ventral Salience network from baseline to end of last cTBS session. <br/ ><br>3.Changes in CGI-I scores from baselineTimepoint: Baseline, Day 8
© Copyright 2025. All Rights Reserved by MedPath